The lectin chaperone calnexin (Cnx) is important for quality control of glycoproteins, and the chances of correct folding of a protein increase the longer the protein interacts with Cnx. Mutations in glycoproteins increase their association with Cnx, and these mutant proteins are retained in the endoplasmic reticulum. However, until now, the increased interaction with Cnx was not known to increase the folding of mutant glycoproteins. Because many human diseases result from glycoprotein misfolding, a Cnx-assisted folding of mutant glycoproteins could be beneficial. Mutations of rhodopsin, the glycoprotein pigment of rod photoreceptors, cause misfolding resulting in retinitis pigmentosa. Despite the critical role of Cnx in glycoprotein folding, surprisingly little is known about its interaction with rhodopsin or whether this interaction could be modulated to increase the folding of mutant rhodopsin. Here, we demonstrate that Cnx preferentially associates with misfolded mutant opsins associated with retinitis pigmentosa. Furthermore, the overexpression of Cnx leads to an increased accumulation of misfolded P23H opsin but not the correctly folded protein. Finally, we demonstrate that increased levels of Cnx in the presence of the pharmacological chaperone 11-cis-retinal increase the folding efficiency and result in an increase in correct folding of mutant rhodopsin. These results demonstrate that misfolded rather than correctly folded rhodopsin is a substrate for Cnx and that the interaction between Cnx and mutant, misfolded rhodopsin, can be targeted to increase the yield of folded mutant protein.
Calnexin is a membrane-bound molecular chaperone of the endoplasmic reticulum (ER) 2 that is an important component of ER protein homeostasis (proteostasis) and participates in QC of glycoproteins (1) (2) (3) . Cnx assists folding of nascent glycoproteins through repeated interactions until they fold properly or are targeted for degradation (4) . Cnx clients include secreted proteins, membrane channels, receptors, and G protein-coupled receptors (5) (6) (7) . The critical role of Cnx in QC of glycoproteins is underscored by embryonic lethality and severe developmental defects that result due to Cnx mutations or knock down (8) . Cnx displays dual behavior with regard to its chaperoning activity with wild type (WT) and mutant glycoproteins. Cnx binds transiently to immature folding intermediates of WT glycoproteins, helping them to fold and exit the ER QC system. Misfolded mutant glycoproteins, on the other hand, are bound stably by Cnx and are retained in the ER (6, 7, 9 -12) . However, enhanced ER retention and prolonged association with Cnx are not known to increase the yields of folded mutant glycoproteins.
ER proteostasis could be manipulated through regulation of molecular chaperone levels alone or in conjunction with pharmacological chaperones (PCs) (3, 13) . Such proteostasis modulation has resulted in ameliorating diseases of protein misfolding. For example, small molecule proteostasis regulators increased cellular heat shock protein levels and increased the amount of trafficking-competent Gaucher disease-related mutant proteins. This increase was further enhanced by presence of a PC (13) . Also, overexpression of heat shock proteins resulted in suppression of some neurodegenerative diseases (14, 15) . However, there is no reported instance of increased folding of a mutant glycoprotein by manipulation of ER proteostasis by increasing cellular levels of Cnx.
Rhodopsin, the prototypical G protein-coupled receptor, is a membrane glycoprotein that is responsible for dim light vision (16) and like most other glycoproteins is folded in the ER (17) . Proper folding of rhodopsin is critically important for visual transduction because light-absorbing pigment is generated by binding of the natural ligand 11-cis-retinal to fully folded opsin. Misfolded opsin is incapable of generating pigment (18, 19) . Mutations throughout rhodopsin cause its misfolding and intracellular aggregation (19 -23) . Mutations within the N-terminal region, for example P23H and T17M, result in improper folding of opsin and poor binding of the ligand (24) (Fig. 1A) . P23H is clinically the most common autosomal dominant RP mutation found in North America. It is located in the N-terminal region of rhodopsin, an integral part of the N-terminal plug that keeps the ligand in its proper position. P23H opsin is a misfolded protein most of which is retained within the ER (19, 22) and is degraded via the ubiquitin-proteasome pathway (20, 21) . Similarly, mutations affecting the sole disulfide bond in rhodopsin (e.g. C110Y) (Fig. 1A ) result in a significantly misfolded molecule. These misfolding mutations negatively affect cellular proteostasis and result in blinding disorders known as retinitis pigmentosa. However, considering the central role of Cnx in glycoprotein folding, surprisingly little is known about the direct interaction of calnexin with WT or mutant rhodopsin.
The few reports that describe Cnx-rhodopsin interaction come from different organisms and have yielded conflicting results (2, 25, 26) . Moreover, none of these reports directly address the role of Cnx in folding of misfolded mutant rhodopsin. An association between misfolded rhodopsin and Cnx was indirectly demonstrated in a mouse model of RP using immunocolocalization. However, no direct biochemical interaction or characterization of this interaction was reported (25) . An important role of Cnx was demonstrated in Drosophila, indicating that Cnx is required for maturation of Rh1 rhodopsin, which is a homolog of mammalian rhodopsin (26) . However, Cnx is not required for maturation of mammalian rhodopsin (2) . This difference in observations is not surprising because Drosophila rhodopsin differs significantly from vertebrate rhodopsin (27) . These results demonstrate that rhodopsin, across phylogenetic lines, is a Cnx substrate and also indicate that the role of Cnx in the QC of rhodopsin may differ among different organisms. Thus, given that mutant, misfolded rhodopsins cause RP, it is important to delineate and clarify the physical interaction of Cnx with mammalian rhodopsin.
Here, we characterize this interaction using cell culture and mouse models of RP. We show that only misfolded rhodopsin is the substrate for Cnx and that the extent of this association directly corresponds with the severity of the mutation. Finally, through modulation of ER proteostasis in the presence of the pharmacological chaperone 11-cis-retinal, we demonstrate that Cnx can increase the efficiency of mutant P23H rhodopsin folding.
EXPERIMENTAL PROCEDURES
Reagents-The antibody against calnexin was obtained from StressGen; tubulin and ubiquitin antibodies were procured from Abcam. 1D4 was obtained from the University of British Columbia. IRdye700-and IRdye800-conjugated secondary antibodies were purchased from LI-COR Biosciences. Dodecyl maltoside was procured from Anatrace. 11-cis-Retinal was a gift from Dr. Rosalie Crouch, Medical University of South Carolina.
Stable Cell Lines and Culture-Tetracycline-inducible stable cell lines used in this study were constructed and cultured as described previously (28) . In addition to P23H and WT opsin genes, C110Y and T17M mutant synthetic bovine opsin genes were also introduced in HEK293 cells using the described method. Opsin production was induced from the stable cell lines by addition of 1 g/ml tetracycline into the culture medium and incubating the cells for 48 h at 5% CO 2 and 37°C. All experiments were carried out at least three times. Representative spectra and Western blots are shown in the figures.
Immunoaffinity Purification of Rhodopsin-After 48 h of incubation, rhodopsin was purified under dim red light from the stable cell lines; SDS-PAGE was conducted, and Western blots were performed essentially as described previously (28) . Briefly, the cells were harvested and washed with ice-cold PBS (10 mM sodium phosphate and 130 mM NaCl, pH 7.2) by centrifuging at 7000 rpm for 10 min. Cell pellets were resuspended in ice-cold PBS and incubated with 50 M 11-cis-retinal for 1 h to regenerate photopigment from opsin produced from the cell lines. The cells were then lysed in PBSD (PBS containing 1.0% dodecyl maltoside and protease inhibitor mixture) for 1 h. The lysate was spun at 13,000 rpm to remove cell debris. The supernatant was collected, and total protein was estimated using the DC protein assay kit (Bio-Rad). Equal amounts of total protein were then added to 1D4-Sepharose immunoaffinity beads and incubated for 1 h at 4°C. The beads were washed three times with cold PBSD (without protease inhibitor) and then two times with 10 mM sodium phosphate buffer, pH 6. Rhodopsin was then eluted from the beads with elution buffer (a competing peptide corresponding to the last 18 amino acids of rhodopsin in the same buffer).
In pharmacological chaperoning experiments, the cells were grown in the presence of the PC for 48 h in the dark after addition of tetracycline. The cells were then harvested and washed with ice-cold PBS and then lysed with PBSD, and rhodopsin was purified exactly as mentioned above. The purified rhodopsin was then scanned in a Cary50 spectrophotometer (Varian) between 250 and 650 nm. The characteristic rhodopsin absorbance at 498 nm (for WT and T17M rhodopsin) and 492 nm (for P23H rhodopsin) was used to quantify pigment yields.
For separation of folded rhodopsin from misfolded opsin, the samples were treated as described above, and then the 1D4-Sepharose immunoaffinity beads were extensively eluted with elution buffer until no rhodopsin was spectrophotometrically detected in the eluate. The misfolded forms of rhodopsin were then eluted with the competing peptide mixed with PBSD.
Rhodopsin Purification from Mice Eyes-All procedures were conducted according to approved IACUC protocols. The procedure was conducted under dim red light. One-month-old C57 and P23H hemizygous mice (29) were sacrificed by cervical dislocation, and entire eyes were removed. Both eyes from one mouse were pooled, and 1 ml of PBSD was added. The eyes were sonicated three times for 5 s each. The suspension was rotated end to end for 1 h at 4°C. Further steps in rhodopsin purification were the same as those described for cell culture.
Calnexin Overexpression-For overexpression of calnexin, whole-length calnexin in pCMV-SPORT6 (p-SPORT6-Cnx) mammalian expression vector (Invitrogen) was transiently transfected in WT and P23H opsin-producing stable cell lines using Lipofectamine transfection reagent (Invitrogen). Plates were incubated for 48 h after which opsin production was induced for another 48 h. The cells were then harvested, and rhodopsin was purified as described earlier.
Immunoprecipitation-In experiments where rhodopsin was not purified for spectrophotometric analysis, whole cell lysates were quantified for total protein, and equal protein was loaded onto 1D4-Sepharose beads. After 1 h of binding, the beads were washed three times for 5 min each, and the bound proteins were directly eluted with 100 M C-18 peptide. The eluted proteins were then subjected to SDS-PAGE and Western blot analysis.
RESULTS

Cnx Preferentially
Associates with Mutant Opsin-To assess the effect of P23H mutation on the levels of total opsin production and on the levels of properly folded rhodopsin, we stably expressed WT and P23H opsin in HEK293 cells. As a control, we used the HEK293 stable cell line expressing only the empty vector. Total opsin levels were 10-fold lower in P23H cells than in WT cells (Fig. 1B, left panel) . Next, we determined the levels of correctly folded rhodopsin from WT and P23H cells using selective immunoaffinity methods described previously (22, 23) . Immunoblots of folded rhodopsin from the two cell lines showed the same relationship between P23H and WT rhodopsin levels as was seen for total opsin (Fig. 1B, middle  panel) . After exhaustive elution of folded rhodopsin, we collected the remaining misfolded opsin. Western blots of these misfolded opsins showed more misfolded P23H opsin than misfolded WT opsin in terms of their ratio to total opsins (Fig. 1B,  right panel) . The control cells containing the empty vector did not produce any detectable opsin (Fig.  1B, all panels) . Because folded rhodopsin has a distinct absorption at 498 nm, folded rhodopsin from these cells was spectrophotometrically analyzed and compared (Fig.  1C) . No detectable absorbance was seen for vector control cells (Fig. 1C , dotted spectrum). A very small amount of 498-nm absorbing pigment was recovered from P23H cells (Fig. 1C, dashed spectrum) , and the yield of WT rhodopsin was 10-fold more than P23H rhodopsin (boldface spectrum). We also analyzed the levels of Cnx in cell lysates to determine whether expression of opsin affected Cnx expression. Cellular Cnx levels did not show any appreciable difference related to opsin expression in these cells (Fig. 1D) .
To identify molecular chaperones associated with rhodopsin, eluates of either the correctly folded or misfolded fractions were probed on immunoblots for different chaperones. Cnx immunoblots revealed specific association of Cnx with misfolded fractions of both P23H (Fig. 1E , upper panel) and WT opsins (Fig. 1E, upper panel) . No Cnx was detected in control lanes or correctly folded P23H and WT lanes (Fig. 1E, upper panel) . (For the rest of this article, "folded" means correctly folded, in contrast to misfolded.) We also probed the folded and misfolded rhodopsin for ubiquitination. The misfolded fractions of both P23H and WT rhodopsin were highly ubiquitinated (Fig. 1E , lower panel). Folded WT rhodopsin did not show any detectable ubiquitination. However, folded P23H rhodopsin showed traces of ubiquitination, reflecting a difference between the folded forms of the two proteins (Fig. 1E , lower panel, arrow points to the position of ubiquitin signal in lane 3). The folded and misfolded fractions were also probed for the presence of calreticulin, because many glycoproteins that interact with Cnx also interact with calreticulin. No trace of associated calreticulin was detected in the Western blots. Hsp70 also was not detected in the blots (data not shown).
To better quantify the relative amounts of Cnx and ubiquitin associated with rhodopsin, their ratio to total opsin was determined. We found that 45-fold more Cnx and 15-fold more ubiquitin were associated with P23H than with WT (Fig.  1F, middle and right panels) .
Prolonged Cnx Association with Mutant Opsin-Because misfolded P23H and WT rhodopsin were highly ubiquitinated, we investigated their fates as ER-associated degradation substrates. To study this, we expressed P23H and WT opsin in the presence of the proteasome inhibitor MG132, which resulted in a 2-fold increase in P23H opsin levels, indicating preservation from degradation ( Fig. 2A, upper  panel) . The WT opsin levels increased only by 10% ( Fig. 2A,  upper panel) . A marginal increase in the amount of WT opsin reflected that only a small fraction of it was misfolded and targeted for degradation through the proteasome. We next determined the levels of Cnx bound to MG132-treated WT and P23H opsins. Cnx immunoblots of MG132-treated P23H cells showed 2-fold more Cnx bound with the misfolded fractions ( Fig. 2A, lower  panel) . No increase in bound Cnx was seen for WT opsin ( Fig. 2A,  lower panel) , possibly because a 10% increase may not be sufficient for detection of differences in Cnx levels.
We further investigated whether the folded forms of the two opsins were also targeted for proteasomal degradation. On treatment with MG132, the amount of pigment increased by 20% for P23H (Fig. 2B, upper panel) and 10% for WT rhodopsin (Fig. 2B, lower panel) . A 20% increase in folded protein suggests that folded P23H rhodopsin is also targeted for proteasomal degradation but to a lesser extent than its misfolded counterpart. Different molecular chaperones interact with newly folded proteins at different times during biogenesis. To determine whether Cnx interacted early with rhodopsin, we induced WT and P23H cells for 6, 12, and 24 h, after which we immunoprecipitated rhodopsin and compared opsin and Cnx levels. Total opsin levels increased steadily with time for both WT and P23H opsins (Fig. 2C) . The maximum amount of Cnx (4-fold) was recovered at 6 h, which was the earliest time point tested after opsin induction (Fig. 2D) . At later time points the rhodopsin/Cnx ratio decreased (Fig. 2, D and E) . These data demonstrate that recognition by Cnx is an early event during opsin biosynthesis (when the bulk of Cnx is bound to the nascent opsin molecules), presumably helping them to fold.
We further characterized the stability of the Cnx-rhodopsin interaction to determine whether this relationship was transient or long lasting. We induced P23H and WT cells for 12 h (0 h in Fig. 2F ) and then added cycloheximide to stop further protein synthesis. Cells were harvested at 12, 24, and 36 h after cycloheximide treatment, and opsin was immunoprecipitated. Opsin levels fell sharply for P23H after cycloheximide addition, indicating rapid cellular clearance (Fig. 2F, left panel) . WT opsin, on the other hand, was more stable and cleared more slowly from the cells (Fig. 2F, right panel) . For P23H, immunoblots showed increased Cnx levels until 24 h after inhibition of protein synthesis (Fig.  2G, left panel) , which is in sharp contrast with WT, for which associated Cnx levels reached steady-state levels in half the time (i.e. 12 h) (Fig.  2G, right panel) . These observations demonstrate the transient nature of Cnx association with WT but a prolonged Cnx association with P23H opsin.
Pharmacological Chaperone Reduces Cnx Association with Mutant Rhodopsin-We next investigated the effect of opsin conformation on Cnx association by inducing P23H opsin to fold in the presence of a PC (11-cis-retinal). P23H and WT cells were expressed in the presence of the PC. Immunoblot of cell lysates showed a 5-fold increase in opsin levels in PC-treated P23H cells compared with untreated controls (Fig. 3A) . WT opsin levels were not affected appreciably in either case (Fig. 3A, lanes 3 and 4) , indicating the absence of any significant amounts of misfolded forms in the total rhodopsin pool. The effect of PC on the folded forms was determined spectrophotometrically; 5-fold more pigment was detected from PC-treated P23H cells (Fig. 3B) than untreated P23H cells. Pigment levels were not affected by the presence of PC in WT cells (Fig. 3B, superimposed dashed spectra) . The yield of mis- folded opsin was reduced 2-fold in PC-treated P23H cells (Fig.  3C) . Misfolded WT opsin levels did not change appreciably with PC addition (Fig. 3C) .
Furthermore, we investigated the effect of PC on Cnx binding to misfolded rhodopsin. Cnx preferentially associated with misfolded opsins (Fig. 3D) . Normalization of associated Cnx levels with total opsin levels revealed a 3-fold reduction of Cnx when PC was added (Fig. 3D) . For WT rhodopsin, the bound Cnx levels did not change with PC treatment (Fig. 3D) . Cellular Cnx levels did not change appreciably when rhodopsin production was induced in the presence of PC (Fig. 3F) .
Because non-native forms of proteins are ubiquitinated and marked for degradation during QC, we also studied the effect of PC on the amount of ubiquitinated P23H opsin. Ubiquitination of misfolded opsins from the PC-treated cells was reduced compared with untreated cells (Fig. 3E) . Correctly folded P23H rhodopsin showed ubiquitination ( Fig. 1E; Fig. 3E, arrow) , which was significantly reduced on addition of PC. The difference in the levels of opsin generated, bound Cnx, and ubiquitination in the absence or presence of the PC are quantified in Fig. 3G .
Cnx Associates with Other RP-causing Mutants of RhodopsinHaving observed enhanced Cnx association with misfolded P23H rhodopsin, we investigated this association in two other RP-associated mutants (i.e. T17M and C110Y). To determine whether greater Cnx association was specific for P23H or was a more general feature of misfolded opsins, we expressed mutant T17M and C110Y stably in HEK293 cells. The mutation T17M also abolishes one of the glycosylation sites (Asn-15) on rhodopsin. First, we studied the effect of the PC on these mutants. Opsin immunoblots showed only minute traces of the C110Y protein in either the absence or presence of the PC (Fig. 4A) . T17M, on the other hand, produced 5-fold more total opsin in the presence of the PC (Fig. 4A) . We then studied the effect of PC on protein folding in these mutants. No pigment formation was observed for C110Y, in either the absence or presence of the PC (Fig. 4B) , demonstrating that the conformation of the mutant could not be induced to fold by pharmacological meth- ods. In contrast, T17M, when expressed in a stable cell line without the aid of the PC, produced only a small amount of pigment (Fig. 4C, dotted spectrum) ; the presence of the PC led to a 5-fold increase in folded rhodopsin (Fig. 4C , boldface spectrum). These observations showed that although T17M could be rescued pharmacologically, C110Y was structurally too distorted to accommodate the PC.
We then studied the nature of Cnx association with these mutants. The amount of bound Cnx showed an inverse correlation with the ability of a mutant to be pharmacologically rescued (Fig. 4D, upper panel) . The greatest amounts of Cnx were associated with C110Y, the most severe mutation, which could not be pharmacologically corrected. The Cnx levels were similar in the presence or absence of the PC, which confirms previous observation that folded rhodopsin levels in C110Y did not differ under similar conditions (Fig. 4B) . In sharp contrast, T17M showed reduction in the levels of associated Cnx in the presence of the PC. In comparison with P23H, C110Y opsin was bound by 2-fold more Cnx, although T17M had 3-fold less Cnx associated with it (Fig. 4D) . We also investigated whether induction of these mutants increased cellular levels of Cnx. As with P23H, Cnx levels were not significantly altered in these cell lines on expression of C110Y and T17M mutant rhodopsin (Fig.  4D, middle panel) .
Having observed that even the folded fractions of P23H opsin were ubiquitinated, we determined whether folded fractions of C110Y and T17M proteins were also ubiquitinated. No trace of ubiquitination was seen in immunoblots of C110Y probably because little opsin could be isolated from these cells. In T17M, on the other hand, ubiquitination was observed in the folded fraction (Fig. 4E, lane 5) . Confirming our previous observation of P23H, ubiquitination of the pharmacologically rescued T17M was reduced with PC treatment (Fig. 4E) .
Cnx and Misfolded Opsin Are Associated in a Mouse
Model of RP-To extend our observations further, we investigated whether our results from cell culture corresponded with a mouse model of RP. Total rhodopsin from the eyes of 1-monthold P23H and C57/B6 (WT) mice was solubilized, and cell lysate was probed for opsin and Cnx. The opsin immunoblots of the lysates revealed 10-fold more rhodopsin in WT mice than in the age-matched P23H mice (Fig. 5A ). This difference in opsin level was also reflected in the levels of folded rhodopsin from the two mice (Fig. 5B) . Total Cnx levels in the lysates of eyes did not differ significantly between WT and P23H mice (Fig. 5A,  middle panel) . We then determined the levels of Cnx associated with the folded and misfolded forms of the two opsins. The folded fractions of both WT and P23H rhodopsin showed no trace of Cnx, which exclusively associated with misfolded forms (Fig. 5C, upper panel) . As observed previously in cell culture, despite the low amounts of total opsin in P23H mice, the misfolded fraction was more ubiquitinated than misfolded WT opsin (Fig. 5C, lower panel) . But unlike cell culture, in which no trace of ubiquitination was seen in folded WT rhodopsin (Fig.  1E and Fig. 3E ), the immunoblots of folded rhodopsin from WT mice showed the presence of ubiquitination (Fig. 5C, lower  panel, lane 1) . The folded rhodopsin fraction from P23H mice showed 2-fold more ubiquitination than WT mice. On normalizing to total opsin, 3-fold more Cnx was associated with rhodopsin isolated from P23H mice than the WT mice (Fig. 5D,  lower panel) . The upper panel in Fig. 5A quantifies the results. Hsp70 and calreticulin were not detected in folded or misfolded fractions of the mouse rhodopsins (data not shown). Collectively, these observations correlate well with our data from the cell culture experiments.
Cnx Overexpression Causes Greater Accumulation of Misfolded P23H Opsin-To further elucidate the importance of the Cnx-rhodopsin association, we overexpressed Cnx in the opsin-producing cell lines. We investigated whether increased cellular Cnx levels led to either the accelerated degradation of misfolded opsin or to its appropriate folding. Cnx constructs were transiently transfected in opsin-producing cell lines. At 48 h post-transfection, Cnx levels increased 2.5-3-fold and remained at that level for the next 24 h (Fig. 6A) . The cell lines were induced to express opsin 48 h after Cnx transfection so that opsin production occurred during increased cellular levels of Cnx. Under these conditions, P23H opsin levels increased by 35% (Fig. 6B, left panel) . However, the WT levels did not increase, suggesting there was no effect of Cnx overexpression on WT levels (Fig. 6B, right panel) . Thus, a preferential accumulation of mutant protein with Cnx overexpression appeared to be present.
We then investigated the effect of PCs on total opsin levels in the presence of overexpressed Cnx. As demonstrated previously, the presence of PC resulted in a 5-fold increase in P23H opsin levels, but no further increase or decrease was observed in this level when Cnx was overexpressed (Fig. 6B, left panel) . Similarly, no increase was seen for WT opsin. A 3-fold higher Cnx association was observed in P23H cells transfected with Cnx in comparison with untransfected cells (Fig. 6C, left panel) . A 3-fold higher Cnx association was also seen in PC-treated cells when Cnx was overexpressed (Fig. 6C, left panel, lanes 3 and 4) . Despite this 3-fold excess of Cnx, P23H opsin levels did not increase in the presence of PC. These observations demonstrate that association with Cnx slows the degradation of the mutant protein. In the presence of the PC, total levels of both opsins do not increase with Cnx overexpression.
Cnx Overexpression Increases the Yield of Folded P23H Opsin Only in the Presence of a PC-Because we observed increased cellular levels of P23H opsin when Cnx was overexpressed, we explored whether this pool of protein included more folded rhodopsin. We compared spectrophotometrically the yields of immunopurified folded rhodopsin generated in the absence or presence of Cnx overexpression alone. No significant increase in the P23H pigment was observed in the presence of only overexpressed Cnx (Fig. 7A, left panel) ; similar to the effect on yield of total WT opsin, no difference in folded WT rhodopsin level was observed in the presence of overexpressed Cnx (Fig. 7A,  middle panel) . These data demonstrate that direct association of increased amounts of Cnx with P23H or WT opsin was not sufficient to increase the yield of folded P23H or WT rhodopsins.
We next investigated the effect of increased Cnx levels on rhodopsin folding in a milieu where opsin molecules were actively assisted to fold (i.e. in the presence of a PC). The amount of folded P23H rhodopsin increased 25% with Cnx overexpression in the presence of the PC (Fig. 7B, left panel) . This effect was specific for the mutant protein, as no such increase was observed in the case of WT (Fig. 7B, right panel) . Because the previous experiments showed that the total P23H opsin levels did not increase in the presence of both the overexpressed Cnx and the PC, the selective increase in folded P23H rhodopsin indicated an increased, intracellular efficiency of mutant rhodopsin folding.
DISCUSSION
In this study, we examined the interaction of Cnx with WT and mutant opsins associated with RP. Cnx preferentially associates with the misfolded fraction of WT and mutant opsins. These fractions were also highly ubiquitinated. The folded WT rhodopsin was not bound to Cnx and was not ubiquitinated. However, the folded forms of the P23H and T17M rhodopsin, even though not bound to Cnx, were mildly ubiquitinated. Because rhodopsin is a substrate for proteasomal degradation (20, 21) , ubiquitination of these folded molecules may be the reason for their lower recovery in comparison with WT rhodopsin. The degradation of WT and P23H opsins was inhibited by MG132, demonstrating that they are substrates for the proteasome. Although to a lesser extent, even folded WT and P23H rhodopsin accumulated with proteasome blockage, indicating that similar to the misfolded opsin, the folded rhodopsin pool in the cell is susceptible to the proteasome. The fact that folded P23H was ubiquitinated was reflected in the higher accumulation of P23H-folded than WT-folded rhodopsin.
Association with Cnx serves different functions for WT and mutant glycoproteins, based on studies of different model proteins. Cnx functions as a folding chaperone for WT glycoproteins (10, 30) , but it only increases the cellular retention of mutant glycoproteins. In addition, the association of WT glycoproteins with Cnx is transient, whereas for mutants Cnx association can be prolonged and stable (5, 7, 11, 12, 31, 32) . Our study results showed a similar dual role of Cnx for WT and mutant rhodopsin. Its association with WT rhodopsin was transient, although it could be detected with P23H opsin for extended periods despite very low levels of the P23H protein.
Immunoprecipitation of C110Y and T17M revealed that Cnx association was not limited to P23H opsin but was a more general feature of misfolded mutants. The extent of Cnx association with the three mutant opsins varied with the nature of the mutation. The largest amount of Cnx precipitated with C110Y, the most severe mutation of the three studied and clinically the most severe phenotype among them. More Cnx was associated with P23H than with T17M; P23H is clinically more severe than T17M. Significantly less association of Cnx with T17M, in our experiments, may be the consequence of both the loss of one of the two glycosylation sites of rhodopsin by this mutation and also the inherent misfolded state of this protein. Because P23H and T17M produce similar levels of folded rhodopsin, the association of significantly more Cnx with P23H may be responsible for the greater severity of P23H than T17M. A similar distinction was seen between two types of mutants of fukutin-related protein that cause congenital muscular dystrophy. The mutant proteins that bound more Cnx (S221R, A455D, and P448L) caused more severe diseases than L276I, which did not bind with Cnx to the same extent and caused less severe disease (11) .
Our observations of the rhodopsin isolated from WT and P23H mice showed a direct correlation with our cell culture observations. In WT as well as P23H mice, only the misfolded fractions of opsin associated with Cnx. Additionally, on a unit opsin basis, significantly greater amounts of Cnx were bound to rhodopsin from P23H mice than from WT mice. Misfolded forms of opsin from both mice were also highly ubiquitinated. However, unlike the cell culture experiments (where no trace of ubiquitination was seen for folded forms of WT rhodopsin), in our observations the folded rhodopsin from WT mice was ubiquitinated; this may reflect a potentially more stringent QC monitoring system in the rod photoreceptor cell or possibly a higher proportion of molecules in non-native conformations.
Incubation of P23H and T17M cells with PC showed significant reduction in the amounts of Cnx bound with mutant rhodopsins. However, Cnx levels did not fall for C110Y with the addition of a PC because of the severe alteration of the structure of the protein, which is too severe to be corrected by the presence of a PC. Therefore, the mutants that responded to the PC showed reduction of bound Cnx, whereas the mutant that was insensitive to the presence of the PC did not show any reduction in bound Cnx levels. This clearly demonstrates that Cnx association with rhodopsin is conformationdependent. Taken together, our observations with misfolded rhodopsin agree strongly with reports from other mutant glycoproteins that demonstrate a reciprocal relationship between the effect of a PC and the amounts of Cnx bound to misfolded proteins (31, 33, 34) .
It is generally accepted that the longer a glycoprotein associates with Cnx, the more likely that correct folding of the protein will be achieved (35) . This is, however, applicable only to WT glycoproteins, because longer association of Cnx with mutant glycoproteins is not known to increase their folding. Previous studies on modulation of ER proteostasis showed that Cnx overexpression may not have any effect on some proteins, although it may increase the expression of other WT glycoproteins, suggesting that the effect of this intervention is substratespecific (30, 36 -39) . We utilized a similar approach to determine what role Cnx has in controlling either the folding or degradation of opsin. WT rhodopsin levels did not change with Cnx overexpression, whereas P23H levels increased indicating that increased Cnx levels led to greater ER QC stringency but did not enhance opsin degradation. However, under these conditions, we did not observe an increase of P23H pigment, which provides direct biochemical evidence that Cnx by itself did not assist in the folding of mutant rhodopsin and corroborates a recent report indicating that Cnx does not affect maturation of rhodopsin (2) .
Proteostasis modulation in the presence of a PC was tested previously for human gonadotropin-releasing hormone receptor (GnRHR). Cnx overexpression in the presence of a PC increased the amount of folded WT receptor. However, in the case of the mutant, such an effect could not be ascertained. An increased amount of Cnx was found to be associated with the mutant, but it could not be determined whether this treatment resulted in plasma membrane localization of the mutant, which is indicative of more efficient folding and trafficking (40) . Because we have previously demonstrated that PCs assist folding of misfolded P23H (22, 23, 28) , we reasoned that addition of a PC might provide the right folding milieu to test whether a folding component of Cnx could be deciphered in such a folding-prone environment. The presence of the PC alone increased the levels of P23H opsin/rhodopsin 5-fold, but with Cnx overexpression in the presence of the PC, no further increase in total P23H opsin level was seen. However, analysis of the folded P23H rhodopsin generated under these conditions, as measured by pigment levels, showed a 25% increase over folded P23H rhodopsin generated in the presence of PC alone. Our results suggest that Cnx holds P23H opsin in a degradation-protected but functionally misfolded state until the PC can assist the actual folding. Because the total opsin level did not increase, the increase in folded rhodopsin may reflect an equilibrium shift toward the folded state, in which more of the misfolded proteins tend to fold. Our results also indicate that Cnx can participate in increasing the efficiency of the folding process in the ER when cellular conditions are favorable to folding. Furthermore, the effect was selective for P23H, because no difference in WT rhodopsin yield was observed.
In summary, we have characterized the physical interaction of Cnx with rhodopsin and provide evidence that this interaction can be targeted to increase the yields of correctly folded mutant rhodopsin. In the future, it may be possible to increase cellular calnexin levels via small molecule or gene therapy approaches. Such a targeted approach may provide a general method for treating protein conformational disorders.
